1. 1509TiPRandomized phase II trial of osimertinib with or without local consolidation therapy (LCT) for patients with EGFR-mutant metastatic NSCLC (NORTHSTAR). (23rd October 2018) Authors: Elamin, Y Y; Antonoff, M; Blakely, C; Baggstorm, M; Bivona, T; Le1, X; Louie, A V; Doebele, R C; Rusthoven, C; Lee, P; Govindan, R; Swisher, S G; Papadimitrakopoulou, V A; Heymach, J V; Gomez, D R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1928PPathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC). (23rd October 2018) Authors: Weissferdt, A; Sepesi, B; Pataer, A; Kalhor, N; Moran, C A; William, W N; Le, X; Glisson, B; Skoulidis, F; Blumenschein, G; Zhang, J; Altan, M; Rice, D; Mehran, R; Lee, J J; Vaporciyan, A; Gibbons, D L; Swisher, S G; Heymach, J V; Cascone, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LBA49Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC). (23rd October 2018) Authors: Cascone, T; William, W N; Weissferdt, A; Leung, C H; Federico, L; Haymaker, C; Bernatchez, C; Fossella, F V; Mott, F E; Papadimitrakopoulou, V A; Byers, L; Lam, V K; Godoy, M C; Carter, B; Lee, J J; Vaporciyan, A; Gibbons, D L; Swisher, S G; Heymach, J V; Sepesi, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗